Josef Priller

Prof Josef Priller

Group Leader

Defining and modulating myeloid cell function in neurodegenerative diseases

Biography

Prof Josef Priller is Chair of Brain Inflammation at the University of Edinburgh and Repair and Professor of Neuropsychiatry at Charité University Berlin. After studying medicine at the Max-Planck-Institute of Medicine and Psychiatry, he went on to specialise in neurology and psychiatry, with a particular interest in inflammation, bridging clinical work and basic research in the lab. As a UK DRI Group Leader, he leads a novel research programme at the UK DRI at Edinburgh using stem cells to investigate microglia in neurodegenerative diseases.

News

Key publications

The lancet. Psychiatry
Published
The trajectory of sedative adverse events caused by antipsychotics: a meta-analysis of individual participant data from randomised, placebo-controlled, clinical trials in acute phase schizophrenia
Authors
Nobuyuki Nomura, Spyridon Siafis, Johannes Schneider-Thoma, Lasse Brandt, Jinyoung Park, Orestis Efthimiou, Josef Priller, John M Davis, Hiroyoshi Takeuchi, Stefan Leucht
The trajectory of sedative adverse events caused by antipsychotics: a meta-analysis of individual participant data from randomised, placebo-controlled, clinical trials in acute phase schizophrenia
The lancet. Psychiatry
Published
Efficacy of clozapine versus second-generation antipsychotics in people with treatment-resistant schizophrenia: a systematic review and individual patient data meta-analysis
Authors
Johannes Schneider-Thoma, Tasnim Hamza, Konstantina Chalkou, Spyridon Siafis, Shimeng Dong, Irene Bighelli, Wulf-Peter Hansen, Elfriede Scheuring, John M Davis, Josef Priller, Pierre Baumann, Robert Conley, Joachim Cordes, Deanna Kelly, Michael Kluge, Sanjiv Kumra, Shôn Lewis, Herbert Y Meltzer, Dieter Naber, Nina Schooler, Jan Volavka, Kristian Wahlbeck, Georgia Salanti, Stefan Leucht
Efficacy of clozapine versus second-generation antipsychotics in people with treatment-resistant schizophrenia: a systematic review and individual patient data meta-analysis
Brain communications
Published
CSF biomarkers are differentially linked to brain areas high and low in noradrenaline, dopamine and serotonin across the Alzheimer's disease spectrum
Authors
Lena Haag, Elisa Lancini, Renat Yakupov, Gabriel Ziegler, Yeo-Jin Yi, Falk Lüsebrink, Wenzel Glanz, Oliver Peters, Eike Jakob Spruth, Slawek Altenstein, Josef Priller, Luisa Sophie Schneider, Xiao Wang, Lukas Preis, Frederic Brosseron, Nina Roy-Kluth, Klaus Fliessbach, Michael Wagner, Steffen Wolfsgruber, Luca Kleineidam, Alfredo Ramirez, Annika Spottke, Frank Jessen, Jens Wiltfang, Anja Schneider, Niels Hansen, Ayda Rostamzadeh, Katharina Buerger, Michael Ewers, Robert Perneczky, Daniel Janowitz, Boris-Stephan Rauchmann, Stefan Teipel, Ingo Kilimann, Doreen Goerss, Christoph Laske, Matthias H Munk, Michael Heneka, Peter Dechent, Stefan Hetzer, Klaus Scheffler, Emrah Düzel, Matthew J Betts, Dorothea Hämmerer
CSF biomarkers are differentially linked to brain areas high and low in noradrenaline, dopamine and serotonin across the Alzheimer's disease spectrum
Alzheimer's & dementia (Amsterdam, Netherlands)
Published
Artificial intelligence-based rapid brain volumetry substantially improves differential diagnosis in dementia
Authors
Jan Rudolph, Johannes Rueckel, Jörg Döpfert, Wen Xin Ling, Jens Opalka, Christian Brem, Nina Hesse, Maria Ingenerf, Vanessa Koliogiannis, Olga Solyanik, Boj F Hoppe, Hanna Zimmermann, Wilhelm Flatz, Robert Forbrig, Maximilian Patzig, Boris-Stephan Rauchmann, Robert Perneczky, Oliver Peters, Josef Priller, Anja Schneider, Klaus Fliessbach, Andreas Hermann, Jens Wiltfang, Frank Jessen, Emrah Düzel, Katharina Buerger, Stefan Teipel, Christoph Laske, Matthis Synofzik, Annika Spottke, Michael Ewers, Peter Dechent, John-Dylan Haynes, Johannes Levin, Thomas Liebig, Jens Ricke, Michael Ingrisch, Sophia Stoecklein
Artificial intelligence-based rapid brain volumetry substantially improves differential diagnosis in dementia

Priller Lab

Explore the work of the Priller Lab, developing cutting-edge techniques to help advance research into the role of microglia in neurodegenerative diseases

Priller Lab
A slice of brain tissue stained with a blue marker